Abemaciclib With or Without Atezolizumab for mCRPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Metastatic Castration-resistant Prostate Cancer
Related studies linked through entity extraction aliases.
A Study of AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1
Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101)
- Status
- TERMINATED
- Phase
- PHASE1
Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
SHR7390 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib
- Status
- COMPLETED
- Phase
- PHASE3
Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Open-label Dose Escalation Phase 1b Trial of a New Micellar Docetaxel Compound in Patients With mCRPC
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trial of Selegiline Plus Docetaxel for the Treatment of Metastatic, Castrate-resistant Prostate Adenocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of FT-7051 in Men With MCRPC
- Status
- TERMINATED
- Phase
- PHASE1
PLX2853 in Combination With Abiraterone Acetate and Prednisone and in Combination With Olaparib in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
[177Lu]Ludotadipep Treatment in Patients With Metastatic Castration-resistant Prostate Cancer.
- Status
- COMPLETED
- Phase
- PHASE1
Enzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Abemaciclib (LY2835219) in Men With Heavily Treated Metastatic Castration-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pharmacodynamic and Genetic Parameters of Abira-DES Study Participants (NCT02217566) - Participants With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Following Unresponsive Treatment With Diethylstilbestrol
- Status
- COMPLETED
- Phase
- N/A
PRECISE, a Study to Gather More Information About Bone Fractures and Survival in Castration-resistant PRostate Cancer (CRPC) patiEnts Treated With Radium-223 in Routine Clinical practIce in SwedEn
- Status
- COMPLETED
- Phase
- N/A
A Study of Copanlisib Combined With Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)
- Status
- TERMINATED
- Phase
- PHASE1